The store will not work correctly when cookies are disabled.
ID: ALA4285086
Max Phase: Preclinical
Molecular Formula: C15H15NO6S2
Molecular Weight: 369.42
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: COc1c(/C=C/CO)c(NS(=O)(=O)c2cccs2)cc2c1OCO2
Standard InChI: InChI=1S/C15H15NO6S2/c1-20-14-10(4-2-6-17)11(8-12-15(14)22-9-21-12)16-24(18,19)13-5-3-7-23-13/h2-5,7-8,16-17H,6,9H2,1H3/b4-2+
Standard InChI Key: WWEHHALAXXRNLT-DUXPYHPUSA-N
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Properties
Molecular Weight: 369.42 | Molecular Weight (Monoisotopic): 369.0341 | AlogP: 2.29 | #Rotatable Bonds: 6 |
Polar Surface Area: 94.09 | Molecular Species: ACID | HBA: 7 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 6.09 | CX Basic pKa: | CX LogP: 1.72 | CX LogD: 0.91 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.81 | Np Likeness Score: -0.52 |
References
1. (2016) Compounds, compositions and methods for inhibiting cnksr1, |
2. (2018) Methods and compositions for inhibiting cnksr1, |
3. (2016) Compounds, compositions and methods for inhibiting cnksr1, |